AU2002322169B2 - Derivatives of morphine-like opioid compounds - Google Patents

Derivatives of morphine-like opioid compounds Download PDF

Info

Publication number
AU2002322169B2
AU2002322169B2 AU2002322169A AU2002322169A AU2002322169B2 AU 2002322169 B2 AU2002322169 B2 AU 2002322169B2 AU 2002322169 A AU2002322169 A AU 2002322169A AU 2002322169 A AU2002322169 A AU 2002322169A AU 2002322169 B2 AU2002322169 B2 AU 2002322169B2
Authority
AU
Australia
Prior art keywords
compound
formula
radical
reacting
krs
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
AU2002322169A
Other languages
English (en)
Other versions
AU2002322169A1 (en
Inventor
William Roy Jackson
Kamani Rupika Subasinghe
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Monash University
Neuro Therapeutics Ltd
Original Assignee
Monash University
Neuro Therapeutics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from AUPR6938A external-priority patent/AUPR693801A0/en
Priority claimed from AUPR9640A external-priority patent/AUPR964001A0/en
Application filed by Monash University, Neuro Therapeutics Ltd filed Critical Monash University
Priority to AU2002322169A priority Critical patent/AU2002322169B2/en
Publication of AU2002322169A1 publication Critical patent/AU2002322169A1/en
Application granted granted Critical
Publication of AU2002322169B2 publication Critical patent/AU2002322169B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A61K31/485—Morphinan derivatives, e.g. morphine, codeine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/02—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with oxygen atoms attached in positions 3 and 6, e.g. morphine, morphinone
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/09—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: containing 4aH-8, 9 c-Iminoethano- phenanthro [4, 5-b, c, d] furan ring systems condensed with carbocyclic rings or ring systems
    • C07D489/10—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: containing 4aH-8, 9 c-Iminoethano- phenanthro [4, 5-b, c, d] furan ring systems condensed with carbocyclic rings or ring systems with a bridge between positions 6 and 14
    • C07D489/12—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: containing 4aH-8, 9 c-Iminoethano- phenanthro [4, 5-b, c, d] furan ring systems condensed with carbocyclic rings or ring systems with a bridge between positions 6 and 14 the bridge containing only two carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02—Silicon compounds
    • C07F7/08—Compounds having one or more C—Si linkages
    • C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804—Compounds having Si-O-C linkages

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
AU2002322169A 2001-08-10 2002-08-09 Derivatives of morphine-like opioid compounds Ceased AU2002322169B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU2002322169A AU2002322169B2 (en) 2001-08-10 2002-08-09 Derivatives of morphine-like opioid compounds

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
AUPR6938 2001-08-10
AUPR6938A AUPR693801A0 (en) 2001-08-10 2001-08-10 Therapeutic compounds
AUPR9640A AUPR964001A0 (en) 2001-12-19 2001-12-19 Therapeutic compounds
AUPR9640 2001-12-19
PCT/AU2002/001088 WO2003014122A1 (en) 2001-08-10 2002-08-09 Derivatives of morphine-like opioid compounds
AU2002322169A AU2002322169B2 (en) 2001-08-10 2002-08-09 Derivatives of morphine-like opioid compounds

Publications (2)

Publication Number Publication Date
AU2002322169A1 AU2002322169A1 (en) 2003-06-19
AU2002322169B2 true AU2002322169B2 (en) 2008-10-30

Family

ID=25646773

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2002322169A Ceased AU2002322169B2 (en) 2001-08-10 2002-08-09 Derivatives of morphine-like opioid compounds

Country Status (7)

Country Link
US (1) US7199129B2 (cg-RX-API-DMAC7.html)
EP (1) EP1423392B1 (cg-RX-API-DMAC7.html)
JP (1) JP2005500373A (cg-RX-API-DMAC7.html)
AT (1) ATE341552T1 (cg-RX-API-DMAC7.html)
AU (1) AU2002322169B2 (cg-RX-API-DMAC7.html)
DE (1) DE60215195T2 (cg-RX-API-DMAC7.html)
WO (1) WO2003014122A1 (cg-RX-API-DMAC7.html)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040204862A1 (en) * 2003-04-11 2004-10-14 Wainer Irving W. Computer-based model for identification and characterization for non-competitive inhibitors of nicotinic acetylcholine receptors and related ligand-gated ion channel receptors
TWI630208B (zh) 2008-12-08 2018-07-21 歐陸斯迪公司 二氫羥戊甲嗎啡
US9351973B2 (en) 2011-09-22 2016-05-31 Merck Sharp & Dohme Corp. Pyrazolopyridyl compounds as aldosterone synthase inhibitors
WO2013043518A1 (en) 2011-09-22 2013-03-28 Merck Sharp & Dohme Corp. Imidazopyridyl compounds as aldosterone synthase inhibitors
EP2757883B1 (en) 2011-09-22 2021-01-13 Merck Sharp & Dohme Corp. Triazolopyridyl compounds as aldosterone synthase inhibitors
WO2014015157A2 (en) 2012-07-19 2014-01-23 Philadelphia Health & Education Corporation Novel sigma receptor ligands and methods of modulating cellular protein homeostasis using same
GB201309654D0 (en) 2013-05-30 2013-07-17 Euro Celtique Sa Method
US9920836B2 (en) * 2013-10-18 2018-03-20 Kabushiki Kaisha Riken Piston ring for internal combustion engine
US11117870B2 (en) 2017-11-01 2021-09-14 Drexel University Compounds, compositions, and methods for treating diseases

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3341538A (en) * 1965-06-18 1967-09-12 Geigy Chem Corp Certain 2, 6-methano-3-benzazocines
WO1999038869A1 (en) * 1998-01-29 1999-08-05 Monash University Therapeutic compounds

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100602929B1 (ko) * 2000-08-31 2006-07-20 에프. 호프만-라 로슈 아게 알파-1 아드레날린성 길항제로서 퀴나졸린 유도체

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3341538A (en) * 1965-06-18 1967-09-12 Geigy Chem Corp Certain 2, 6-methano-3-benzazocines
WO1999038869A1 (en) * 1998-01-29 1999-08-05 Monash University Therapeutic compounds

Also Published As

Publication number Publication date
WO2003014122A1 (en) 2003-02-20
EP1423392A4 (en) 2004-11-17
ATE341552T1 (de) 2006-10-15
US20040242616A1 (en) 2004-12-02
DE60215195D1 (de) 2006-11-16
JP2005500373A (ja) 2005-01-06
US7199129B2 (en) 2007-04-03
DE60215195T2 (de) 2007-08-23
EP1423392A1 (en) 2004-06-02
EP1423392B1 (en) 2006-10-04

Similar Documents

Publication Publication Date Title
US6784186B1 (en) Therapeutic compounds
US6534514B1 (en) Kappa opioid receptor antagonists
KR102038260B1 (ko) 히드로코돈의 벤조산, 벤조산 유도체 및 헤테로아릴 카르복실산 콘쥬게이트, 이의 전구약물, 제조 방법 및 용도
JP6794602B2 (ja) ポリアミド化合物及びその使用
EP2046800B1 (en) 6-carboxy-normorphinan derivatives, synthesis and uses thereof
US5739145A (en) Antitussive agents
AU4300799A (en) Imidazo pyridine derivatives which inhibit gastric acid secretion
AU2003290630A1 (en) Process for the preparation of quaternary n-alkyl morphinan alkaloid salts
JPWO1993015081A1 (ja) モルヒナン誘導体および医薬用途
KR20090086627A (ko) 프로드러그 및 그것의 제조 및 사용 방법
US20120149900A1 (en) Fluorine containing compounds and methods of use thereof
EP1423392B1 (en) Derivatives of morphine-like opioid compounds
US20090156630A1 (en) Anti-tumour polycyclic carboxamides
EP2398807A1 (en) (+)-6-hydroxy-morphinan or (+)-6-amino-morphinan derivatives
HUP0500024A2 (hu) 6-Aminomorfinán-származékok, alkalmazásuk és az ezeket tartalmazó gyógyászati készítmények
AU2002322169A1 (en) Derivatives of morphine-like opioid compounds
JP2014073964A (ja) モルヒナン誘導体
EP0770081B1 (en) Heterocycle-condensed morphinoid derivatives
US5834478A (en) Morphinan hydroxamic acid compounds
US20060111381A1 (en) Amidine compounds
US6271239B1 (en) Delta opioid receptor-selective benzylidene-substituted morphinans
AU2003266841A1 (en) Amidine compounds
JP2005500373A5 (cg-RX-API-DMAC7.html)
AU757975C (en) Therapeutic compounds
WO2000008027A1 (en) Kappa (op2) opioid receptor antagonists

Legal Events

Date Code Title Description
FGA Letters patent sealed or granted (standard patent)
MK14 Patent ceased section 143(a) (annual fees not paid) or expired